Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone

Completed · Phase 2

Conditions studied: Contraception, Hypogonadism

In brief

The purpose of this study is to test the how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future. We will be administering three drugs. Dutasteride is FDA approved to treat prostate enlargement. Lupron is approved for treatment of prostate cancer. Testosterone is approved for treatment of testicular insufficiency. They are being used in this study for "off-label" research purposes. This study will allow us to find out the effect of food on two formulations of testosterone taken by mouth, and the relative effect of food on testosterone absorption. Information from this study may be useful in treatment of men with low testosterone levels and the development of a male hormonal contraceptive.

Key facts

Study ID

NCT00161421

Run by

University of Washington

People needed

18

Starts

2005-03-01

Expected to finish

2006-07-01

Last updated by the study team

2008-09-19

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male 18-50 yrs old
• In good general health based on normal screening evaluation (consisting of medical history, physical exam, normal serum chemistry, hematology, and baseline hormone levels)

You may not qualify if…

• Poor general health, with abnormal blood results at screening
• A known history of alcohol or drug abuse
• Participation in a long-term male contraceptive study within three months of screening

Where it is running

• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.